Aug 17, 2018
27:25
For every 25 shares held, investors received 27. The price per share adjusted from $22.90 to $21.20.
The split itself did not change the total investment value.
Welgene Biotech Co., Ltd. (TPEX:6661) operates in the Medical specialties industry.
Welgene Biotech Co., Ltd. company overviewWelgene Biotech Co., Ltd.'s most recent stock split was on August 17, 2018. It was a 27-for-25 forward split, so shareholders received 27 shares for every 25 they held.
Welgene Biotech Co., Ltd. has split its stock once. This history records one forward split, on August 17, 2018.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Welgene Biotech Co., Ltd.'s 27-for-25 split on August 17, 2018, every 25 shares became 27 shares.
Welgene Biotech Co., Ltd. has not announced a new split in our records. Its most recent split was on August 17, 2018, 8 years ago. Companies announce splits in advance, and any new TPEX:6661 split will appear on this page.
Already premium?